Unknown

Dataset Information

0

Low-grade BRAF V600E mutant oligodendroglioma-like tumors of children may show EGFR and MET amplification.

ABSTRACT:

SUBMITTER: Yang RR 

PROVIDER: S-EPMC8018073 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Low-grade BRAF V600E mutant oligodendroglioma-like tumors of children may show EGFR and MET amplification.

Yang Rui Ryan RR   Li Kay Ka-Wai KK   Liu Anthony P Y APY   Chen Hong H   Chung Nellie Yuk-Fei NY   Chan Aden K Y AKY   Li Fangcheng F   Chan Danny Tat-Ming DT   Mao Ying Y   Shi Zhi-Feng ZF   Ng Ho-Keung HK  

Brain pathology (Zurich, Switzerland) 20201102 1

Similar Datasets

Unknown BRAF V600E mutant oligodendroglioma-like tumors with chromosomal instability in adolescents and young adults.
| S-EPMC8018140 | biostudies-literature
Unknown Molecular mechanisms underlying the resistance of BRAF V600E-mutant metastatic colorectal cancer to EGFR/BRAF inhibitors.
| S-EPMC9210093 | biostudies-literature
Unknown Combined BRAF, EGFR, and MEK Inhibition in Patients with <i>BRAF</i><sup>V600E</sup>-Mutant Colorectal Cancer.
| S-EPMC5882509 | biostudies-literature
Unknown Combined BRAF<sup>V600E</sup> and MEK blockade for BRAF<sup>V600E</sup>-mutant gliomas.
| S-EPMC5560871 | biostudies-literature
Unknown Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma.
| S-EPMC11096001 | biostudies-literature
Unknown Management of V600E and V600K BRAF-Mutant Melanoma.
| S-EPMC10176035 | biostudies-literature
Unknown A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAF<sup>V600E</sup> colorectal tumors.
| S-EPMC9970872 | biostudies-literature
Unknown ETV1-Positive Cells Give Rise to <i>BRAF<sup>V600E</sup></i> -Mutant Gastrointestinal Stromal Tumors.
| S-EPMC5513719 | biostudies-literature
Unknown Evolution of MET and NRAS gene amplification as acquired resistance mechanisms in EGFR mutant NSCLC.
| S-EPMC8511249 | biostudies-literature
Unknown Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma.
| S-EPMC4907264 | biostudies-literature